Toll Free: 1-888-928-9744

Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022

Published: Aug, 2017 | Pages: 104 | Publisher: QYResearch
Industry: ICT | Report Format: Electronic (PDF)

This report studies the global Parkinsons Disease Drugs market, analyzes and researches the Parkinsons Disease Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Merck
    Akorn
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Valeant Pharmaceuticals

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Parkinsons Disease Drugs can be split into
    Madopar
    Sinemet-CR
    Trastal
    COMT Inhibitor
    Other

Market segment by Application, Parkinsons Disease Drugs can be split into
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

If you have any special requirements, please let us know and we will offer you the report as you want.


 Table of Contents

Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Parkinsons Disease Drugs
    1.1  Parkinsons Disease Drugs Market Overview
        1.1.1 Parkinsons Disease Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Parkinsons Disease Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Parkinsons Disease Drugs Market by Type
        1.3.1 Madopar
        1.3.2 Sinemet-CR
        1.3.3 Trastal
        1.3.4 COMT Inhibitor
        1.3.5 Other
    1.4 Parkinsons Disease Drugs Market by End Users/Application
        1.4.1 Under 40 Years Old
        1.4.2 40-65 Years Old
        1.4.3 Above 65 Years Old

2 Global Parkinsons Disease Drugs Competition Analysis by Players
    2.1 Parkinsons Disease Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 GSK
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Novartis
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Boehringer Ingelheim
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Teva Pharmaceutical
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Abbvie
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Merck
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Akorn
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Kyowa Hakko Kirin Pharma
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Astellas Pharma
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Desitin Arzneimittel
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Endo Pharmaceuticals
    3.12 F.Hoffmann-La Roche
    3.13 H.Lundbeck
    3.14 Valeant
    3.15 Apokyn
    3.16 Orion
    3.17 Stada Arzneimittel
    3.18 US WorldMeds
    3.19 Valeant Pharmaceuticals

4 Global Parkinsons Disease Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Parkinsons Disease Drugs Market Size by Type (2012-2017)
    4.2 Global Parkinsons Disease Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Parkinsons Disease Drugs in Future
    4.4 Top Consumer/End Users of Parkinsons Disease Drugs

5 United States Parkinsons Disease Drugs Development Status and Outlook
    5.1 United States Parkinsons Disease Drugs Market Size (2012-2017)
    5.2 United States Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Parkinsons Disease Drugs Development Status and Outlook
    6.1 EU Parkinsons Disease Drugs Market Size (2012-2017)
    6.2 EU Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Parkinsons Disease Drugs Development Status and Outlook
    7.1 Japan Parkinsons Disease Drugs Market Size (2012-2017)
    7.2 Japan Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Parkinsons Disease Drugs Development Status and Outlook
    8.1 China Parkinsons Disease Drugs Market Size (2012-2017)
    8.2 China Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Parkinsons Disease Drugs Development Status and Outlook
    9.1 India Parkinsons Disease Drugs Market Size (2012-2017)
    9.2 India Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Parkinsons Disease Drugs Development Status and Outlook
    10.1 Southeast Asia Parkinsons Disease Drugs Market Size (2012-2017)
    10.2 Southeast Asia Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Parkinsons Disease Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Parkinsons Disease Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Parkinsons Disease Drugs Market Size by Application (2017-2022)

12 Parkinsons Disease Drugs Market Dynamics
    12.1 Parkinsons Disease Drugs Market Opportunities
    12.2 Parkinsons Disease Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Parkinsons Disease Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Parkinsons Disease Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and FiguresList of Tables and Figures

    Figure Parkinsons Disease Drugs Product Scope
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) (2012-2017)
    Table Global Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Parkinsons Disease Drugs Market Share by Regions in 2016
    Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Parkinsons Disease Drugs Market Share by Type in 2016
    Figure Madopar Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Sinemet-CR Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Trastal Market Size (Million USD) and Growth Rate (2012-2017)
    Figure COMT Inhibitor Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Parkinsons Disease Drugs Market Share by Application in 2016
    Table Key Downstream Customer in Under 40 Years Old
    Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Under 40 Years Old (2012-2017)
    Table Key Downstream Customer in 40-65 Years Old
    Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in 40-65 Years Old (2012-2017)
    Table Key Downstream Customer in Above 65 Years Old
    Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Above 65 Years Old (2012-2017)
    Table Parkinsons Disease Drugs Market Size (Million USD) by Players (2016 and 2017)
    Figure Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure Parkinsons Disease Drugs Market Size Share by Players in 2017
    Table GSK Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of GSK (2012-2017)
    Figure GSK Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Novartis Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Novartis (2012-2017)
    Figure Novartis Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Boehringer Ingelheim Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
    Figure Boehringer Ingelheim Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Teva Pharmaceutical Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Teva Pharmaceutical (2012-2017)
    Figure Teva Pharmaceutical Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Abbvie Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Abbvie (2012-2017)
    Figure Abbvie Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Merck Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Merck (2012-2017)
    Figure Merck Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Akorn Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Akorn (2012-2017)
    Figure Akorn Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Kyowa Hakko Kirin Pharma Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2012-2017)
    Figure Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Astellas Pharma Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Astellas Pharma (2012-2017)
    Figure Astellas Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Desitin Arzneimittel Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Desitin Arzneimittel (2012-2017)
    Figure Desitin Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Endo Pharmaceuticals Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Endo Pharmaceuticals (2012-2017)
    Figure Endo Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table F.Hoffmann-La Roche Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of F.Hoffmann-La Roche (2012-2017)
    Figure F.Hoffmann-La Roche Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table H.Lundbeck Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of H.Lundbeck (2012-2017)
    Figure H.Lundbeck Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Valeant Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant (2012-2017)
    Figure Valeant Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Apokyn Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Apokyn (2012-2017)
    Figure Apokyn Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Orion Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Orion (2012-2017)
    Figure Orion Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Stada Arzneimittel Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Stada Arzneimittel (2012-2017)
    Figure Stada Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table US WorldMeds Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of US WorldMeds (2012-2017)
    Figure US WorldMeds Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Valeant Pharmaceuticals Basic Information List
    Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017)
    Figure Valeant Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016
    Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2012-2017)
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2012
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2013
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2014
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2015
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2016
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017
    Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2012-2017)
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2012
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2013
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2014
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2015
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2016
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Parkinsons Disease Drugs
    Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2017
    Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2017
    Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2017
    Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure China Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure China Parkinsons Disease Drugs Market Size Share by Players in 2017
    Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure India Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure India Parkinsons Disease Drugs Market Size Share by Players in 2017
    Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2016
    Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2017
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022)
    Table Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022)
    Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2017
    Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2022
    Figure United States Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2017-2022)
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017
    Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2022
    Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2017-2022)
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017
    Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2022

 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3300
Multi User - US $6600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify